CHRISTA DUFF: Open Payments
NPI 1295201432 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 63 payments from 13 companies in 2025. Trend: 2023 $551 · 2024 $918 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $424 |
| Gilead Sciences, Inc. | 8 | $251 |
| Madrigal Pharmaceuticals | 10 | $156 |
| Janssen Biotech, Inc. | 4 | $84 |
| Lilly USA, LLC | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Ardelyx, Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
Products named: RINVOQ, REZDIFFRA, Livdelzi, MAVYRET, LINZESS, TREMFYA, OMVOH, ENTYVIO.
Industry payments across KY — which companies pay providers there.
